Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 662.20
-5.20 (-0.78%)
At close: Dec 18, 2025
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 203.57 million as of December 19, 2025. Its market cap has decreased by -24.19% in one year.
Market Cap
203.57M
Enterprise Value
157.12M
Revenue
n/a
Ranking
n/a
PE Ratio
184.58
Stock Price
662.20
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 203.57M, a decrease of -83.12%. That is a compound annual growth rate of -35.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 21, 2025 | 203.57M | -24.83% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 111.55B |
| Danel (Adir Yeoshua) | 2.75B |
| Kamada | 1.38B |
| BrainsWay | 1.04B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 999.21M |
| Ilex Medical | 737.86M |
| Novolog (Pharm-Up 1966) | 650.34M |